LDS/Medical Tests/Acetylcholine Receptor (AChR) Antibody

Acetylcholine Receptor (AChR) Antibody

Acetylcholine receptor (AChR) antibodies are involved in the disease process of myasthenia gravis (MG). MG is an autoimmune disorder characterized by muscle weakness and fatigue. The disease is caused when AChR antibodies block or destroy receptors for the neurotransmitter acetylcholine, leading to muscle weakness and fatigue. The disease usually presents itself in younger women (age 40 years or less) and older men (over 55-60 years old). A transient form of the disease can be found in neonates born to women with MG (called transient neonatal myasthenia), in which antibodies cross the placenta from mother to baby and result in weak fetal cry, poor sucking and generalized low muscle tone. There are 3 types of antibodies to AChR:

  • Binding antibody can activate complement and lead to loss of AChR
  • Blocking antibody may impair ACh ability to bind to the receptor and lead to muscle weakness and poor muscle contraction
  • Modulating antibody causes receptor endocytosis, resulting in loss of AChR expression. This correlates most closely with clinical severity of disease.

Approximately 10-20% of individuals with confirmed myasthenia gravis have no measurable binding, blocking, or modulating antibody. MG presents with the following clinical presentation: muscle weakness that worsens after affected muscles are used (fatigable weakness), but recovers after rest or anticholinesterase therapy, bulbar symptoms, dysphagia, dysarthria, extraocular muscle (EOM) weakness (diplopia, ptosis). The disease is usually treated with anti-cholinesterase drugs, thymectomy, immunosuppression and plasmapheresis. Acetylcholine receptor (AChR) antibody is reasonably sensitive in diagnosing the disease; however, if symptoms are limited to eye muscle weakness, the antibody test is negative about 50% of the time.

  • Confirm diagnosis of myasthenia gravis
  • Differential diagnosis of amyotrophic lateral sclerosis (ALS) – Lou Gehrig’s disease
  • Differential diagnosis of botulism
  • Differential diagnosis of poliomyelitis
  • Differential diagnosis of drug-related myopathy

Positive in:

  • Myasthenia gravis

Negative in:

  • Amyotrophic lateral sclerosis (ALS)
  • Lou Gehrig’s disease
  • Botulism
  • Poliomyelitis
  • Drug-related myopathy

The AChR binding antibody assay is the assay of choice for confirming a diagnosis of acquired MG. AChR binding antibodies are characteristic of, but not diagnostic for, acquired MG. A patient’s clinical presentation must be taken into account, and test results must be interpreted by the physician in the context of other findings.

Negative (Non-reactive)
Note: Negative does not rule out MG.

 

 

Sensitive Radioimmunoassay and Radioreceptor Assay; ELISA is available based on inhibition of binding labeled bungarotoxin to the acetylcholine receptor.

Serum (SST). 

Stability

  • Ambient: Unacceptable
  • Refrigerated: 14 days
  • Frozen: 60 days

Striated Muscle Antibody, IgG with Reflex to Titer, Antinuclear Antibody, Thyroglobulin Antibody, Thyroperoxidase Antibody, TSH, T4, MRI/CT of Thymus, Rheumatioid Factor, Anticholinesterase Test (usually Edrophonium), Single Fiber Electromyography, Repetitive Nerve Stimlation, Anti-Striational Antibodies,Striated Muscle Antibody, IgG with Reflex to Titer, Antinuclear Antibody, Thyroglobulin Antibody, Thyroperoxidase Antibody, TSH, T4, MRI/CT of Thymus, Rheumatioid Factor, Anticholinesterase Test (usually Edrophonium), Single Fiber Electromyography, Repetitive Nerve Stimlation, Anti-Striational Antibodies,

3-6 days after receipt in performing laboratory.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Neuromuscul Disord. 2006;16:459. [PMID: 16793269]
  • Acta Neurol Scand. 2006 Aug;114(2):124-32. [PMID: 16867036]
  • Ann N Y Acad Sci. 2003 Sep;998:324-35. [PMID: 14592891]
  • Ann NY Acad Sci. 505 (1987), pp. 526–538 [PMID: 3479935]
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757